1. US Food and Drug Administration. FDA News Release. FDA approves first gene therapies to treat patients with sickle cell disease. Available at: https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapies-treat-patients-sickle-cell-disease. Accessed Dec 10, 2023.
2. GOV.UK. Press Release. MHRA authorises world-first gene therapy that aims to cure sickle-cell disease and transfusion-dependent β-thalassemia. Available at: https://www.gov.uk/government/news/mhra-authorises-world-first-gene-therapy-that-aims-to-cure-sickle-cell-disease-and-transfusion-dependent-thalassemia. Accessed Dec 10, 2023.
3. Centers for Disease Control and Prevention. Sickle cell disease (SCD). Data & statistics on sickle cell disease. Available at: https://www.cdc.gov/ncbddd/sicklecell/data.html#:∼:text=SCD%20affects%20approximately%20100%2C000%20Americans,sickle%20cell%20trait%20(SCT). Accessed Dec 10, 2023.
4. CRISPR-Cas9 Gene editing for sickle cell disease and β-thalassemia;Frangul;N Engl J Med,2021
5. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity;Jinek;Science,2012